Curious what the Johnson and Johnson's approach to developing its vaccine was in as far as if it was different from the other developers. The only thing I've been able to zero in on so far is the possibility of a single dose. What I'm actually more curious about however, is Johnson and Johnson using a more traditional approach with the development of its vaccine or is it doing what the other developers have done utilizing genetic activators...(not sure if that's the proper term or not?)
Thanks!
Thanks!